Meningococcal carriage among Hajj pilgrims, risk factors for carriage and records of vaccination: a study of pilgrims to Mecca

Trop Med Int Health. 2021 Apr;26(4):453-461. doi: 10.1111/tmi.13546. Epub 2021 Jan 31.

Abstract

Objective: The Saudi government requires that all pilgrims receive a quadrivalent meningococcal vaccine at least 10 days before the Hajj. We conducted a study to determine the uptake of meningococcal vaccine and antibiotic use. We also investigated risk factors of meningococcal carriage and carriage of Neisseria meningitidis pathogenic serogroups A, C, W and Y.

Methods: A cross-sectional oropharyngeal carriage survey was conducted in 2973 Hajj pilgrims in September 2017. A real-time polymerase chain reaction (rt-PCR) assay was used to identify N. meningitidis from the oropharyngeal swabs. A questionnaire investigated potential risk factors for carriage of N. meningitidis.

Results: Two thousand two hundred forty nine oropharyngeal swabs were obtained. The overall prevalence of carriage of N. meningitidis was 4.6% (95% CI: 3.4%-6%). Carriage of pathogenic serogroups was not associated significantly with any of the meningococcal risk factors evaluated. 77% of pilgrims were vaccinated but 22.58 % said they were carrying unofficial vaccination cards.

Conclusion: Carriage of serogroups A, C, W and Y was not significantly associated with any of the risk factors investigated. Almost a quarter of pilgrims were unlikely to have been vaccinated, highlighting a need to strengthen compliance with the current policy of vaccination to prevent meningococcal disease outbreaks during and after the Hajj.

Keywords: Neisseria meningitides; Hajj; antibiotic; meningococcal; pharyngeal carriage; vaccination.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Anti-Bacterial Agents / therapeutic use*
  • Carrier State / diagnosis
  • Carrier State / epidemiology
  • Carrier State / microbiology
  • Carrier State / prevention & control*
  • Cross-Sectional Studies
  • Female
  • Humans
  • Islam
  • Male
  • Meningococcal Infections / microbiology
  • Meningococcal Infections / prevention & control*
  • Meningococcal Vaccines*
  • Middle Aged
  • Neisseria meningitidis* / genetics
  • Neisseria meningitidis* / growth & development
  • Patient Acceptance of Health Care
  • Prevalence
  • Risk Factors
  • Saudi Arabia / epidemiology
  • Self Medication
  • Serogroup
  • Travel*
  • Vaccination Coverage
  • Vaccination*
  • Young Adult

Substances

  • Anti-Bacterial Agents
  • Meningococcal Vaccines